subject area of
- Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia Journal Articles
- Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders Journal Articles
- Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia Journal Articles
- Epidemiology of VITT Journal Articles
- Epidemiology of VITT. Journal Articles
- Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 Journal Articles
- Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2 Journal Articles
- In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant) Journal Articles
- In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose Journal Articles
- Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia Journal Articles
- Recommendations for the clinical and laboratory diagnosis of VITT against COVID‐19: Communication from the ISTH SSC Subcommittee on Platelet Immunology Journal Articles
- Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination Journal Articles
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination Journal Articles
- Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT) Journal Articles
- Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil Journal Articles
- Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination Journal Articles